Kasvu Therapeutics Revenue

Biotechnology Research • Helsinki, Uusimaa, Finland • 11-20 Employees

Kasvu Therapeutics revenue & valuation

Annual revenue	$941,105
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,100,000
Total funding	No funding

Key Contacts at Kasvu Therapeutics

Jami Mandelin

Co-Founder And Ceo

Satu Juhila

Research Program Director

Company overview

Headquarters	Helsinki, Uusimaa, Finland
Phone number	+35810321041
Website	kasvutx.com
NAICS	541714
Keywords	Mental Health, Neuropsychiatry, Neurodegeneration, Neuroplasticity
Employees	11-20

Kasvu Therapeutics Email Formats

Kasvu Therapeutics uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@kasvutx.com), used 100% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@kasvutx.com	100%

About Kasvu Therapeutics

We harness the power of neuroplasticity. Potent, rapid-acting and long-lasting without hallucinations – Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

C-Suite

Director

Employees by Department

Kasvu Therapeutics has 3 employees across 3 departments.

Departments

Number of employees

Funding Data

Kasvu Therapeutics has never raised funding before.

Frequently asked questions

Kasvu Therapeutics is located in Helsinki, Uusimaa, FI.

You can reach Kasvu Therapeutics at +35810321041.

Kasvu Therapeutics generates an estimated annual revenue of $941,105. This revenue figure reflects the company's market position and business performance in its industry.

Kasvu Therapeutics has an estimated valuation of $3,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Kasvu Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at Kasvu Therapeutics

Jami Mandelin

Co-Founder And Ceo

Satu Juhila

Research Program Director

4.8

40,000 users